Novartis (NVS) News Today $115.97 -0.44 (-0.38%) Closing price 06/18/2025 03:59 PM EasternExtended Trading$115.70 -0.27 (-0.23%) As of 06/18/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)June 18 at 11:30 PM | theglobeandmail.comCWA Asset Management Group LLC Acquires 6,806 Shares of Novartis AG (NYSE:NVS)CWA Asset Management Group LLC grew its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 22.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 37,646 shares of the company's stJune 18 at 7:00 AM | marketbeat.comBroderick Brian C Lowers Position in Novartis AG (NYSE:NVS)Broderick Brian C trimmed its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 47.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,273 shares of the company's stock after selJune 18 at 5:50 AM | marketbeat.comSagespring Wealth Partners LLC Has $642,000 Stock Holdings in Novartis AG (NYSE:NVS)Sagespring Wealth Partners LLC increased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 67.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,759 shares of the company's stock after buyJune 18 at 4:23 AM | marketbeat.comJanney Montgomery Scott LLC Cuts Stake in Novartis AG (NYSE:NVS)Janney Montgomery Scott LLC cut its holdings in Novartis AG (NYSE:NVS - Free Report) by 10.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 224,038 shares of the company's stock after selling 25,584 shaJune 18 at 4:14 AM | marketbeat.comTrust Point Inc. Makes New $613,000 Investment in Novartis AG (NYSE:NVS)Trust Point Inc. acquired a new position in Novartis AG (NYSE:NVS - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 5,496 shares of the company's stock, valued at approximately $613,000. Several otherJune 17 at 4:17 AM | marketbeat.comHanson & Doremus Investment Management Has $505,000 Stock Position in Novartis AG (NYSE:NVS)Hanson & Doremus Investment Management grew its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 624.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,528 shares of the company's stock after acquiring an addJune 16 at 6:19 AM | marketbeat.comBerenberg Bank Maintains a Hold Rating on Novartis (NVS)June 15, 2025 | msn.comDeutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PTJune 15, 2025 | msn.comFarmers & Merchants Investments Inc. Sells 4,756 Shares of Novartis AG (NYSE:NVS)Farmers & Merchants Investments Inc. reduced its stake in Novartis AG (NYSE:NVS - Free Report) by 10.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 40,541 shares of the company's stock after selling 4,756 shares during the quarter. FJune 15, 2025 | marketbeat.comFifth Third Bancorp Sells 20,417 Shares of Novartis AG (NYSE:NVS)Fifth Third Bancorp lessened its stake in Novartis AG (NYSE:NVS - Free Report) by 46.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,925 shares of the company's stock after selling 20,417 shares during thJune 15, 2025 | marketbeat.comAzzad Asset Management Inc. ADV Has $3.92 Million Stock Holdings in Novartis AG (NYSE:NVS)Azzad Asset Management Inc. ADV decreased its position in shares of Novartis AG (NYSE:NVS - Free Report) by 6.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,163 shares of the company's stock after sellJune 14, 2025 | marketbeat.comBerenberg Bank Sticks to Its Hold Rating for Novartis AG (NOVN)June 14, 2025 | theglobeandmail.comYousif Capital Management LLC Sells 6,280 Shares of Novartis AG (NYSE:NVS)Yousif Capital Management LLC reduced its holdings in Novartis AG (NYSE:NVS - Free Report) by 18.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,525 shares of the company's stock after selling 6,280 shares during the quarter. YousiJune 14, 2025 | marketbeat.comRhumbline Advisers Raises Stock Position in Novartis AG (NYSE:NVS)Rhumbline Advisers lifted its position in shares of Novartis AG (NYSE:NVS - Free Report) by 11.1% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 38,600 shares of the company's stock after buying an additional 3,846 shares duringJune 14, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Receives $123.38 Average Price Target from AnalystsJune 14, 2025 | americanbankingnews.com11 Best Drug Stocks to Buy According to Hedge FundsJune 13, 2025 | insidermonkey.comSmithbridge Asset Management Inc. DE Makes New Investment in Novartis AG (NYSE:NVS)Smithbridge Asset Management Inc. DE bought a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 47,989 shares of the company's stock, valued at approximately $5,350,000. Other hJune 13, 2025 | marketbeat.comOsprey Private Wealth LLC Invests $733,000 in Novartis AG (NYSE:NVS)Osprey Private Wealth LLC acquired a new position in shares of Novartis AG (NYSE:NVS - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,575 shares of the company's stock, valued at approximately $733,000. Other hedge fJune 13, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Stock Holdings Boosted by Albert D Mason Inc.Albert D Mason Inc. lifted its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 96.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 26,028 shares of the company's stock after buying an additional 12,774 shJune 13, 2025 | marketbeat.comNovartis (NYSE:NVS) Reaches New 52-Week High - What's Next?Novartis (NYSE:NVS) Reaches New 52-Week High - Still a Buy?June 12, 2025 | marketbeat.comNovartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood DisorderJune 12, 2025 | benzinga.comFarther Finance Advisors LLC Boosts Stock Holdings in Novartis AG (NYSE:NVS)Farther Finance Advisors LLC grew its position in shares of Novartis AG (NYSE:NVS - Free Report) by 27.7% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,628 shares of the company's stockJune 12, 2025 | marketbeat.comNovartis Fabhalta® shows statistically significant and clinically meaningful improvements in hemoglobin in new population of patients with PNHJune 12, 2025 | globenewswire.comNovartis ADR Sees RS Rating Improve To 72June 11, 2025 | msn.comNovartis AG (NYSE:NVS) Receives Average Recommendation of "Hold" from BrokeragesShares of Novartis AG (NYSE:NVS - Get Free Report) have been assigned an average recommendation of "Hold" from the eleven analysts that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a sell rating, six have issued a hold rating, one has given a buy rJune 11, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Sold by OLD National Bancorp INOLD National Bancorp IN decreased its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 26.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,443 shares of the company's stock after seJune 10, 2025 | marketbeat.comGateway Investment Advisers LLC Makes New Investment in Novartis AG (NYSE:NVS)Gateway Investment Advisers LLC acquired a new position in Novartis AG (NYSE:NVS - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 2,642 shares of the company's stock, valued at approximately $295,000. Other lJune 10, 2025 | marketbeat.comBaldwin Wealth Partners LLC MA Lowers Holdings in Novartis AG (NYSE:NVS)Baldwin Wealth Partners LLC MA trimmed its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 14.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,420 shares of the company's stock after seJune 9, 2025 | marketbeat.comPark Avenue Securities LLC Increases Stock Position in Novartis AG (NYSE:NVS)Park Avenue Securities LLC lifted its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 7.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 46,508 shares of the company's stock after purchasing an additional 3,381 shares dJune 9, 2025 | marketbeat.comGodsey & Gibb Inc. Buys 3,170 Shares of Novartis AG (NYSE:NVS)Godsey & Gibb Inc. increased its stake in shares of Novartis AG (NYSE:NVS - Free Report) by 1.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 195,457 shares of the company's stock after buying an addiJune 7, 2025 | marketbeat.com2 Dividend Growth Stocks to Buy and Hold ForeverJune 6, 2025 | msn.comApella Capital LLC Invests $264,000 in Novartis AG (NYSE:NVS)Apella Capital LLC bought a new stake in shares of Novartis AG (NYSE:NVS - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,539 shares of the company's stock, valued at approximately $264,000. Several other insJune 6, 2025 | marketbeat.comMerit Financial Group LLC Has $2.23 Million Holdings in Novartis AG (NYSE:NVS)Merit Financial Group LLC lifted its position in shares of Novartis AG (NYSE:NVS - Free Report) by 85.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 19,978 shares of the company's stock after purchasing aJune 6, 2025 | marketbeat.comIs Novartis Gaining or Losing Market Support?June 4, 2025 | benzinga.comNixon Peabody Trust Co. Decreases Stock Holdings in Novartis AG (NYSE:NVS)Nixon Peabody Trust Co. trimmed its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 81.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,842 shares of the company's stock after selling 34,659 shares during thJune 4, 2025 | marketbeat.com2,930 Shares in Novartis AG (NYSE:NVS) Purchased by Watershed Private Wealth LLCWatershed Private Wealth LLC bought a new stake in shares of Novartis AG (NYSE:NVS - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,930 shares of the company's stock, valued at approximately $327,000. Other hedge funds and other instiJune 4, 2025 | marketbeat.comCapital Asset Advisory Services LLC Purchases Shares of 2,484 Novartis AG (NYSE:NVS)Capital Asset Advisory Services LLC purchased a new stake in Novartis AG (NYSE:NVS - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 2,484 shares of the company's stock, valued at approximately $275,000. Several other large investJune 4, 2025 | marketbeat.comPublic Employees Retirement System of Ohio Sells 173,556 Shares of Novartis AG (NYSE:NVS)Public Employees Retirement System of Ohio lowered its position in Novartis AG (NYSE:NVS - Free Report) by 94.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,700 shares of the company's stock afterJune 4, 2025 | marketbeat.comNBC Securities Inc. Buys 11,608 Shares of Novartis AG (NYSE:NVS)NBC Securities Inc. boosted its position in Novartis AG (NYSE:NVS - Free Report) by 116,080.0% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,618 shares of the company's stock after purchasing aJune 3, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Sees Large Drop in Short InterestNovartis AG (NYSE:NVS - Get Free Report) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 3,350,000 shares, a decline of 27.2% from the April 30th total of 4,600,000 shares. Currently, 0.2% of the company's stock are short sold. Based on an average daily volume of 2,330,000 shares, the days-to-cover ratio is currently 1.4 days.June 2, 2025 | marketbeat.comNovartis’ Pluvicto Shows Promise in Early Stage Prostate CancerJune 2, 2025 | msn.comDouglas Lane & Associates LLC Has $18.89 Million Position in Novartis AG (NYSE:NVS)Douglas Lane & Associates LLC boosted its position in Novartis AG (NYSE:NVS - Free Report) by 7.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 169,475 shares of the company's stock afteJune 2, 2025 | marketbeat.comNovartis AG (NYSE:NVS) Shares Bought by Eldred Rock Partners LLCEldred Rock Partners LLC lifted its position in shares of Novartis AG (NYSE:NVS - Free Report) by 33.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 80,835 shares of the company's stock after buying an addJune 2, 2025 | marketbeat.comNovartis AG: Hold Rating Amid Promising Trials and Competitive ChallengesJune 2, 2025 | tipranks.comCautious Outlook on Novartis AG Amid Promising Pluvicto Trial Results and Market UncertaintiesJune 2, 2025 | tipranks.comClinical trial shows strong results for Novartis’ cancer drugJune 2, 2025 | ca.investing.comGAMMA Investing LLC Acquires 722,272 Shares of Novartis AG (NYSE:NVS)GAMMA Investing LLC boosted its holdings in Novartis AG (NYSE:NVS - Free Report) by 14,376.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 727,296 shares of the company's stock after acquiring an additionalJune 2, 2025 | marketbeat.comNovartis' Pluvicto shown to slow prostate cancer in earlier settingJune 2, 2025 | reuters.comNovartis's Cancer Treatment Pluvicto Shows Positive Results in TrialJune 2, 2025 | wsj.com Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address NVS Media Mentions By Week NVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVS News Sentiment▼1.020.56▲Average Medical News Sentiment NVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVS Articles This Week▼2316▲NVS Articles Average Week Get Novartis News Delivered to You Automatically Sign up to receive the latest news and ratings for NVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NVO News AZN News SNY News GSK News TAK News ARGX News ONC News BNTX News TEVA News SMMT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVS) was last updated on 6/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVS Stock Free NVS Stock Alerts